Zargis Awarded Follow-On U.S. Army Contract; Mandates Expansion of Two Previous Awards
September 29 2009 - 9:00AM
PR Newswire (US)
STAMFORD, Conn., Sept. 29 /PRNewswire/ -- Zargis Medical Corp., a
majority-owned subsidiary of Speedus Corp. (NASDAQ:SPDE) and a
spin-off from Siemens Corporate Research (NYSE:SI) today announced
that it received a contract from the U.S. Army totaling $224,000.
This contract will allow Zargis to develop an investigational
device based on the success of the Signal-X6(TM) telemedicine
systems which Zargis delivered to the Army earlier this month. This
new prototype system will be ruggedized for field-use and allow the
Army to examine the benefits of remote patient analysis and
monitoring of up to 12 simultaneously recorded heart and lung
sounds. This contract also funds completion of the second phase of
development for an Internet case-based learning system. Zargis
began developing this medical education platform for the Army in
2008 and it is currently used by medical residents at a U.S. Army
teaching hospital. After completion of the second phase of this
project next fall, Zargis will offer this innovative software
platform to military and nonmilitary teaching facilities throughout
the world. "We are very encouraged by the continued expansion of
our development efforts with the U.S. Army", said John Kallassy,
Zargis' CEO. "This new contract is a testament to our prior
successes working with the Army to develop innovative solutions in
the fields of remote medical monitoring systems and medical
education." About Zargis Medical Corp. Zargis Medical Corp.
develops advanced diagnostic decision support products and services
for primary care physicians, pediatricians, cardiologists and other
healthcare professionals. Zargis was formed in 2001 when Siemens
Corporate Research, a division of Siemens AG (NYSE:SI), and Speedus
Corp. (NASDAQ:SPDE) co-invested to develop and market an advanced
acoustic technology designed to detect heart abnormalities
identified through analysis of heart sounds. For additional
information about Zargis or Speedus Corp., contact Peter Hodge at
888.773.3669 (ext. 23) or , or visit the following Web sites:
http://www.zargis.com/ and http://www.speedus.com/. Statements
contained herein that are not historical facts, including but not
limited to statements about the Company's product, corporate
identity and focus, may be forward-looking statements that are
subject to a variety of risks and uncertainties. There are a number
of important factors that could cause actual results to differ
materially from those expressed in any forward-looking statements
made by the Company, including, but not limited to, the continuing
development of the Company's sales, marketing and support efforts.
DATASOURCE: Zargis Medical Corp. CONTACT: Peter Hodge, Zargis
Medical Corp., +1-888-773-3669 ext. 23, Web Site:
http://www.zargis.com/
Copyright
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Oct 2023 to Oct 2024